In Vivo and In Vitro Escape from Neutralizing Antibodies 2G12, 2F5, and 4E10

類似資料

• In Vivo Efficacy of Human Immunodeficiency Virus Neutralizing Antibodies: Estimates for Protective Titers
  著者:: Trkola, Alexandra, 等
  出版事項: (2008)
• Long-Term Multiple-Dose Pharmacokinetics of Human Monoclonal Antibodies (MAbs) against Human Immunodeficiency Virus Type 1 Envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5)
  著者:: Joos, Beda, 等
  出版事項: (2006)
• Potent Human Immunodeficiency Virus-Neutralizing and Complement Lysis Activities of Antibodies Are Not Obligatorily Linked
  著者:: Huber, Michael, 等
  出版事項: (2008)
• Virus Isolates during Acute and Chronic Human Immunodeficiency Virus Type 1 Infection Show Distinct Patterns of Sensitivity to Entry Inhibitors
  著者:: Rusert, Peter, 等
  出版事項: (2005)
• Complement Lysis Activity in Autologous Plasma Is Associated with Lower Viral Loads during the Acute Phase of HIV-1 Infection
  著者:: Huber, Michael, 等
  出版事項: (2006)